Events2Join

EU Drug Markets Analysis


EU Drug Markets: In-depth analysis | www.euda.europa.eu

'EU Drug Markets: In-depth analysis' is a strategic and action-oriented analysis of the information available on Europe's illicit drug markets.

EU Drug Markets Analysis 2024 key insights for policy and practice

The report 'EU Drug Markets Analysis 2024' looks at the links between the illicit drugs trade and other crime areas in the European Union, ...

Report: €30 Billion EU Drug Market Is Wily and Strong - OCCRP

A new report from European Union (EU) agencies underscores how extreme drug-related violence is straining local communities and society, ...

EU Drug Markets: In-depth analysis

'EU Drug Markets: In-depth analysis' is a strategic and action-oriented analysis of the information available on Europe's illicit drug markets.

EU drug markets: in-depth analysis. - Drugs and Alcohol

'EU Drug Markets: In-depth analysis' is the fourth comprehensive overview of illicit drug markets in the EU by the EMCDDA and Europol and takes a broad view of ...

2019 EU Drug Markets Report - eucrim

The report finds that the drug market is a major source of income for organised criminal groups (OCGs) in the EU, at a minimum estimated retail value of €30 ...

EU drug markets analysis: key insights for policy and practice.

The European drug market has seen an unprecedented increase in the availability of illicit drugs, evidenced by elevated drug purity and stable prices at retail ...

EU Drug Markets: In-depth analysis - ISSUP

Illicit drugs are big business. They are one of the main profit-generating activities of organised crime and are estimated to represent ...

EU Drug Markets Analysis 2024 Key insights for policy and practice

The EU Drug Markets Analysis 2024 Key insights for policy and practice report by the European Monitoring Centre for Drugs and Drug Addiction and Europol.

EU Drug Market Analysis 2024 - Foundation Drug Free Europe

The full text in: https://www.emcdda.europa.eu/publications/eu-drug-markets/analysis-key-insights-policy-and-practice_en EMCDDA is the European Monitoring ...

EU drug markets analysis 2024: key insights for policy and practice

EMCDDA and Europol raise concerns on the threats of highly potent synthetic substances and the need to invest in harm reduction approaches, ...

EMCDDA-Europol Launch: EU Drug Markets - YouTube

... EU and Member State level will be provided. Background: This webinar is dedicated to the NPS module of the EU Drug Markets: In-depth analysis ...

EU Drug Markets: Drivers and facilitators — new report unveils ...

... drug production, trafficking and distribution. The report is a key element in the EU Drug Markets: In-depth analysis from the two agencies ...

European Union Illegal Drug Market Proves Resilient to Global Crises

The EU retail drug market is estimated to be worth more than €30 billion ($32.7 billion USD), making the supply and trafficking of drugs a ...

Europol Researches EU Drugs Market and Warns Stronger ...

The EU retail drug market is estimated to be worth more than EUR 30 billion annually, making it a major source of income for organised crime.

Key insights for policy and practice (EMCDDA-Europol) - YouTube

On 7 March, the EMCDDA and Europol held an online press conference to launch 'EU Drug Markets: Key insights for policy and practice', ...

EU Drug Markets Report: A Strategic Analysis | Global Initiative

The drug market is a complex place; we cannot fully understand the supply of drugs in Europe if we do not comprehend the changing nature of demand. Patterns of ...

Europol: EU Drug Markets, Analysis - 2024 - Ports Europe

Europol has published its annual report entitled "EU Drug Markets, Analysis - 2024".

EU Drug Markets Analysis, Key insights for Policy and Practice

This section presents key insights from the current analysis of EU drug markets, covering the range of market dynamics, geopolitical factors ...

EU Drug Markets Analysis - Drug Policy Network SEE

The European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) and Europol have published the EU Drug Markets Analysis: Key insights ...